Daniels Karen K. 4
4 · Adamis Pharmaceuticals Corp · Filed Feb 26, 2020
Insider Transaction Report
Form 4
Daniels Karen K.
Vice President of Operations
Transactions
- Sale
Common Stock
2020-02-24$0.60/sh−6,229$3,759→ 157,460 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.615 to $0.608, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.